Inspiralis provides researchers involved in drug development with the necessary tools to develop and screen novel compounds particularly in the anti-infective and anti-cancer areas. Specialising in DNA-modifying proteins, we have been supplying products and services since 2008 including topoisomerases, helicase and ligases. 

We provide enzymes, substrates and assay kits as well as a range of services including compound screening, determination of their mechanism of action, cloning and expression of mutants, and some structural studies. 


Therapeutics

Life Sciences

Biotechnology

Inspiralis Limited

Inspiralis Limited

Org chart

Teams

Similar companies